Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Imaging of Huntington's Disease.
Ciarmiello A, Giovacchini G, Giovannini E, Lazzeri P, Borsò E, Mannironi A, Mansi L. Ciarmiello A, et al. Among authors: mannironi a. J Cell Physiol. 2017 Aug;232(8):1988-1993. doi: 10.1002/jcp.25666. Epub 2017 Mar 24. J Cell Physiol. 2017. PMID: 27791273 Review.
Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition.
Ciarmiello A, Giovannini E, Riondato M, Giovacchini G, Duce V, Ferrando O, De Biasi M, Passera C, Carabelli E, Mannironi A, Mansi L, Tartaglione A. Ciarmiello A, et al. Among authors: mannironi a. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2090-2098. doi: 10.1007/s00259-019-04409-1. Epub 2019 Jul 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 31264171
Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patients.
Ciarmiello A, Tartaglione A, Giovannini E, Riondato M, Giovacchini G, Ferrando O, De Biasi M, Passera C, Carabelli E, Mannironi A, Foppiano F, Alfano B, Mansi L. Ciarmiello A, et al. Among authors: mannironi a. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):288-296. doi: 10.1007/s00259-018-4149-2. Epub 2018 Sep 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 30244387 Free PMC article.
Are basketball players more likely to develop Hirayama disease?
Cabona C, Beronio A, Martinelli I, Briani C, Lapucci C, Serrati C, Delucchi S, Mannironi A, Benedetti L. Cabona C, et al. Among authors: mannironi a. J Neurol Sci. 2019 May 15;400:142-144. doi: 10.1016/j.jns.2019.03.020. Epub 2019 Mar 21. J Neurol Sci. 2019. PMID: 30951991
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group. Sandercock P, et al. Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252. Trials. 2011. PMID: 22129158 Free PMC article. Clinical Trial.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
18 results